| Literature DB >> 22223838 |
Abstract
Objectives To investigate the impact of early sexual debut on HIV seroprevalence and incidence rates among a cohort of women. Design Prospective study. Setting KwaZulu-Natal, South Africa. Participants A total of 3492 sexually active women who consented to screen a HIV prevention trial during September 2002 to September 2005; a total of 1485 of them were followed for approximately 24 months. Primary and secondary outcome measures HIV seroprevalence among those who were screened for the trial and HIV seroconversion among those who seroconverted during the study. Results Lowest quintiles of age at sexual debut, less than high school education, a higher number of lifetime sexual partners and lack of cohabitation, being diagnosed as having herpes simplex virus 2 and other sexually transmitted infections were all significantly associated with prevalent HIV infection in multivariate analysis. During follow-up, 148 (6.8 per 100 person-years, 95% CI 5.8 to 8.0) women seroconverted. Highest seroconversion rate was observed among women who had reported to have had sex 15 years or younger (12.0 per 100 person-years, 95% CI 8.0 to 18.0). Overall, impact of risk factors considered in this study was associated with considerable potential reductions in HIV prevalence and incidence rates (population attributable risk: 85%, 95% CI 84% to 87% and population attributable risk: 77%, 95% CI 72% to 82%, respectively). Conclusions The association of HIV status with younger age at sexual debut may likely due to an increased number of lifetime partners. This increase could result from longer duration of sexual life. Prevention of HIV infection should include efforts to delay age at first sex in young women. Trial registration number NCT00121459.Entities:
Year: 2012 PMID: 22223838 PMCID: PMC3253418 DOI: 10.1136/bmjopen-2011-000285
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Association of various socio-demographic and risk characteristics with age at first sex
| Age at first sex (quintiles) | p Value | |||||
| 1st Quintile <15 years | 2nd Quintile 15–16 years | 3rd Quintile 17–18 years | 4th Quintile 19–20 years | 5th Quintile >20 years | ||
| Demographic factors | ||||||
| Age (years), median (IQR) | 27 (21–34) | 25 (20–32) | 25 (21–32) | 28 (23–34) | 30 (25–35) | <0.001 |
| Less than high school education | 86% | 76% | 71% | 67% | 62% | <0.001 |
| Zulu speaking at home | 96% | 95% | 95% | 92% | 92% | 0.037 |
| Religion—Christian | 91% | 90% | 90% | 90% | 91% | 0.827 |
| Single/not living with a regular sex partner | 88% | 89% | 87% | 85% | 81% | <0.001 |
| Sexual risk behaviours | ||||||
| Using condom (as current contraception) | 45% | 42% | 47% | 45% | 46% | 0.347 |
| Using any contraception | 77% | 77% | 77% | 80% | 78% | 0.784 |
| At least four lifetime sex partners | 39% | 29% | 25% | 18% | 14% | <0.001 |
| Biological risk factors | ||||||
| HIV prevalence | 48% | 43% | 41% | 37% | 33% | <0.001 |
| STI prevalence | 20% | 15% | 14% | 13% | 12% | <0.001 |
| HSV prevalence | 79% | 74% | 71% | 70% | 68% | <0.001 |
Kruskal–Wallis test was used.
HSV, herpes simplex virus; STI, sexually transmitted infection.
Multivariate logistic regression: ORs and 95% CIs for HIV infection
| Univariate analysis | Multivariate analysis | ||||
| Prevalence (%) | OR (95% CI) | p Value | OR (95% CI) | p Value | |
| Age (years) | |||||
| <25 | 41 | 1 | 1 | ||
| 25–29 | 21 | 1.98 (1.66 to 2.38) | <0.001 | 1.52 (1.23 to 1.87) | <0.001 |
| 30–34 | 16 | 1.60 (1.32 to 1.95) | <0.001 | 1.19 (0.94 to 1.50) | 0.142 |
| 35+ | 0.70 (0.58 to 0.85) | <0.001 | 0.50 (0.40 to 0.63) | <0.001 | |
| Age at first sex (years) | |||||
| <15 (1st quintile) | 20 | 1.87 (1.47 to 2.36) | <0.001 | 1.96 (1.53 to 2.51) | <0.001 |
| 15–16 (2nd quintile) | 20 | 1.50 (1.17 to 1.90) | 0.001 | 1.61 (1.25 to 2.08) | <0.001 |
| 17–18 years (3rd quintile) | 20 | 1.41 (1.13 to 1.76) | 0.002 | 1.49 (1.19 to 1.87) | 0.001 |
| 19–20 (4th quintile) | 20 | 1.16 (0.87 to 1.54) | 0.316 | 1.18 (0.89 to 1.59) | 0.251 |
| 21+ (5th Quintile) | 20 | 1 | 1 | ||
| At least high school education | |||||
| Yes | 26 | 1 | 1 | ||
| No | 74 | 1.21 (1.04 to 1.41) | 0.010 | 1.37 (1.15 to 1.62) | <0.001 |
| English spoken at home | |||||
| Yes | 5 | 1 | – | ||
| No | 95 | 1.91 (1.53 to 2.39) | <0.001 | – | |
| Religion | |||||
| Other | 9 | 1 | |||
| Christian | 91 | 1.34 (1.06 to 1.71) | 0.015 | – | |
| Number of lifetime sex partners | |||||
| One | 25 | 1 | 1 | ||
| Two | 28 | 2.49 (2.01 to 3.10) | <0.001 | 1.73 (1.37 to 2.20) | <0.001 |
| Three | 21 | 4.35 (3.47 to 5.44) | <0.001 | 2.82 (2.20 to 3.62) | <0.001 |
| Four or more | 26 | 6.65 (5.35 to 8.26) | <0.001 | 4.09 (3.20 to 5.22) | <0.001 |
| Cohabitation status | |||||
| Married/living with/a sexual partner | 15 | 1 | 1 | ||
| Not married/not living with/a sexual partner | 85 | 7.02 (5.20 to 9.47) | <0.001 | 4.32 (3.11 to 6.00) | <0.001 |
| Have you ever had vaginal sex with condom? | |||||
| No | 30 | 1 | |||
| Yes | 70 | 1.40 (1.21 to 1.63) | <0.001 | – | |
| Using any contraception | |||||
| Yes | 78 | 1 | |||
| No | 22 | 1.36 (1.16 to 1.60) | <0.001 | – | |
| HSV diagnosis | |||||
| No | 27 | 1 | 1 | ||
| Yes | 73 | 7.20 (5.88 to 8.82) | <0.001 | 6.19 (4.98 to 7.70) | <0.001 |
| STI diagnosis | |||||
| No | 84 | 1 | 1 | ||
| Yes | 16 | 1.34 (1.12 to 1.61) | 0.001 | 1.24 (1.02 to 1.51) | 0.038 |
Any of the following: male condom, female condom, pills, injectables, spermicides, withdrawal, long term (partner vasectomy, tubal ligation), other.
Chlamydia, gonorrhoea, syphilis or Trichomonas vaginalis.
HSV, herpes simplex virus; STI, sexually transmitted infection.
Figure 1Time to HIV seroconversion by the quintiles of age at sexual debut.
Estimated crude incidence rates and HRs for time to HIV by the quintiles of age at first sex
| Crude incidence rate per 100 person-years (95% CI) | Unadjusted HR (95% CI) | p Value | Adjusted HR | p Value | |
| Age at first sex (years) | |||||
| <15 | 12.0 (8.0 to 18.0) | 1.97 (1.07 to 3.63) | 0.029 | 1.78 (0.96 to 3.29) | 0.066 |
| 15–16 | 7.2 (5.7 to 9.0) | 1.11 (0.69 to 1.80) | 0.664 | 0.90 (0.53 to 1.46) | 0.633 |
| 17–18 | 6.1 (4.1 to 9.0) | 0.95 (0.53 to 1.69) | 0.851 | 0.82 (0.45 to 1.47) | 0.496 |
| 19–20 | 5.1 (2.9 to 9.0) | 0.78 (0.39 to 1.60) | 0.503 | 0.72 (0.35 to 1.67) | 0.365 |
| 21+ | 6.4 (4.2 to 9.8) | 1 | 1 | ||
Adjusted for age, number of lifetime sex partners, cohabitation status, level of education, ever used condom with vaginal sex.
Estimated PAR (95% CI) for risk factors for the prevalence and incidence of HIV infection in the MIRA trial
| Modifiable risk factors | PAR (95% CI) | PAR (95% CI) |
| Combined effect | ||
| Age at first sex (<15) | 0.26 (0.21 to 0.31) | 0.17 (0.10 to 0.21) |
| Less than high school | 0.13 (0.10 to 0.17) | NA |
| Age at first sex | ||
| + Less than high school | ||
| Not cohabiting | 0.39 (0.35 to 0.43) | 0.54 (0.46 to 0.62) |
| Number of lifetime male sex partners | ||
| Two | 0.12 (0.11 to 0.13) | 0.11 (0.09 to 0.15) |
| Three | 0.20 (0.18 to 0.21) | 0.13 (0.11 to 0.17) |
| Four or more | 0.41 (0.39 to 0.43) | 0.16 (0.13 to 0.20) |
| Biological risk factors | ||
| Tested positive for STI | 0.05 (0.04 to 0.06) | 0.03 (0.02 to 0.05) |
| HSV2 | 0.82 (0.80 to 0.83) | 0.21 (0.14 to 0.31) |
Age adjusted.
Assumes all the risk factors removed from the target population.
Less than 12 years of education.
Level of education was not determined to be significant predictor of HIV seroconversion.
Chlamydia, gonorrhoea, syphilis or Trichomonas vaginalis at screening.
HSV2, herpes simplex virus 2; MIRA, Methods for Improving Reproductive Health in Africa; PAR, Population Attributable Risk; STI, sexually transmitted infection.